Poster Session D - Tuesday Morning
Category: Interventional Endoscopy
Sriya Muralidharan, MD
Duke University
Durham, NC

| Phase 1 | Phase 2 | P1 vs. P2 | ||||
| (N=46) 95% CI | (N=25) 95% CI | p-value | ||||
| Raw Sample Presence ( >100 CFU) | ||||||
| Site 1 | 0 (0%) | 0 (0%) | -- | |||
| (0%, 7.7%) | (0%, 13.7%) | |||||
| Site 2 | 0 (0%) | 1 (4.0%) | 0.35 | |||
| (0%, 7.7%) | (0.1%, 20.4%) | |||||
| Site 3 | 1 (2.2%) | 1 (4.0%) | 0.58 | |||
| (0.1%, 11.5%) | (0.1%, 20.4%) | |||||
| Site 4 | 7 (15.2%) | 0 (0%) | 1.00 | |||
| (6.3%, 28.9%) | (0%, 13.7%) | |||||
| Raw Sample Enterococcus Presence ( >1 CFU) | ||||||
| Site 1 | 2 (4.3%) | 1 (4.0%) | 0.734 | |||
| (0.5%, 14.8%) | (0.1%, 20.4%) | |||||
| Site 2 | 2 (4.3%) | 2 (8.0%) | 0.441 | |||
| (0.5%, 14.8%) | (1.0%, 26.0%) | |||||
| Site 3 | 2 (4.3%) | 2 (8.0%) | 0.441 | |||
| (0.5%, 14.8%) | (1.0%, 26.0%) | |||||
| Site 4 | 0 (0%) | 0 (0%) | -- | |||
| (0%, 7.7%) | (0%, 13.7%) | |||||
| Raw Sample C. difficile Presence ( >1 CFU) | ||||||
| Site 1 | 0 (0%) | 0 (0%) | -- | |||
| (0%, 7.7%) | (0%, 13.7%) | |||||
| Site 2 | 0 (0%) | 0 (0%) | -- | |||
| (0%, 7.7%) | (0%, 13.7%) | |||||
| Site 3 | 0 (0%) | 0 (0%) | -- | |||
| (0%, 7.7%) | (0%, 13.7%) | |||||
| Site 4 | 0 (0%) | 0 (0%) | -- | |||
| (0%, 7.7%) | (0%, 13.7%) | |||||